Association between congenital heart disease and folic acid supplementation during periconceptional period among women of childbearing age in Shaanxi
10.7652/jdyxb201703005
- VernacularTitle:陕西省育龄妇女围孕期服用叶酸与产儿先天性心脏病的关系
- Author:
Shuyi YUAN
;
Hong YAN
;
Lingxia ZENG
;
Qiang LI
;
Quanli WANG
;
Yaling ZHAO
;
Shaonong DANG
- Keywords:
congenital heart disease;
folic acid supplementation;
logistic regression analysis
- From:
Journal of Xi'an Jiaotong University(Medical Sciences)
2017;38(3):343-347
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the association between folic acid supplementation during periconcerptional period and congenital heart disease in newborns to provide scientific evidence for making intervening measures.Methods Using stratified random cluster sampling,a total of 30 counties were sampled from Shaanxi Province.A questionnaire survey was conducted among childbearing-aged women pregnant between January 2010 and November 2013.All of the included women had definite pregnancy outcomes and had signed the consent form.Logistic regression was performed to investigate the association between folic acid supplementation during pregnancy and congenital heart disease in newborns.Results In total,28 354 questionnaires were available for analysis.The overall prevalence of congenital heart disease among live-birth neonates in the present study was 7.3‰.The percentage of childbearing-age women who had taken folic acid supplementation during pregnancy was 64.4％,while only 17.2％ of them took folic acid according to the specification.Taking folic acid regularly during pregnancy was associated with a lower risk of congenital heart disease among the newborns (OR 0.502,95％ CI:0.279 0.902).The multiple-factor analysis results also showed that taking folic acid regularly during periconcerptional period could reduce the risk of congenital heart disease (adjusted OR=0.512,P=0.046) when we controlled the family background factors,mother factors and exposure risk factors during pregnancy.However,no association was found between irregularly taking folic acid during periconcerptional period and the risk of congenital heart disease.Conclusion Taking folic acid according to the specification during periconcerptional period (taking folic acid during 3 months before pregnancy to 3 months after pregnancy with a daily dose of 0.4mg for more than 90 days) may prevent congenital heart disease of newborns.
